Helen E. Jolin
- Immunology top 0.5%
- IL-33, ST2, and ILC Pathways 24
- Immune Cell Function and Interaction 19
- Toxin Mechanisms and Immunotoxins 1
- Surgery top 1%
- Eosinophilic Esophagitis 10
- Immunology and Allergy top 2%
- Physiology top 2%
- Asthma and respiratory diseases 8
- Parasitology top 2%
-
- Autoimmune and Inflammatory Disorders Research 2
-
- PI3K/AKT/mTOR signaling in cancer 2
- Melanoma and MAPK Pathways 2
- Co-authors
- Andrew N. J. McKenziePadraic G. FallonSee Heng WongJillian L. BarlowDaniel R. NeillRichard PannellMaria DalyColleen Kane
- Journals
- Immunity (5 papers)The Journal of Experimental Medicine (4 papers)The Journal of Immunology (3 papers)
- Partner nations
- United KingdomIrelandGermany
In The Last Decade
Helen E. Jolin
36 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 4.2k
- Surgery 2.3k
- Immunology and Allergy 304
- Physiology 1.2k
- Parasitology 274
Countries citing papers authored by Helen E. Jolin
This map shows the geographic impact of Helen E. Jolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Jolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Jolin more than expected).
Fields of papers citing papers by Helen E. Jolin
This network shows the impact of papers produced by Helen E. Jolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Jolin. The network helps show where Helen E. Jolin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen E. Jolin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2022 | 26 | |
| 3 | 2020 | 59 | |
| 4 | 2020 | 35 | |
| 5 | 2020 | 11 | |
| 6 | 2018 | 198 | |
| 7 | 2015 | 76 | |
| 8 | 2014 | 35 | |
| 9 | 2012 | 480 | |
| 10 | 2011 | 12 | |
| 11 | Nuocytes represent a new innate effector leukocyte that mediates type-2 immunitybreakdown → | 2010 | 1632 |
| 12 | 2009 | 254 | |
| 13 | Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsionbreakdown → | 2006 | 596 |
| 14 | 2004 | 14 | |
| 15 | 2004 | 60 | |
| 16 | 2004 | 115 | |
| 17 | 2003 | 46 | |
| 18 | 2000 | 90 | |
| 19 | 2000 | 129 | |
| 20 | 1996 | 98 |
About Helen E. Jolin
Helen E. Jolin is a scholar working on Immunology, Immunology and Allergy and Physiology, having authored 36 papers that have together received 5.7k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (24 papers), Immune Cell Function and Interaction (19 papers), Eosinophilic Esophagitis (10 papers), Asthma and respiratory diseases (8 papers), Autoimmune and Inflammatory Disorders Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Melanoma and MAPK Pathways (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Immunology (4.2k citations), Surgery (2.3k citations) and Immunology and Allergy (304 citations). Helen E. Jolin has collaborated with scholars based in United Kingdom, Ireland and Germany. Frequent co-authors include Andrew N. J. McKenzie, Padraic G. Fallon, See Heng Wong, Jillian L. Barlow, Daniel R. Neill, Richard Pannell, Maria Daly, Colleen Kane, Robin J. Flynn and Christine M. Bucks. Their work appears in journals such as Immunity, The Journal of Experimental Medicine, The Journal of Immunology, Nature Immunology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.